Does this phase 1B trial require dose / safety escalation? Or is it max strength all the way?
- Forums
- ASX - By Stock
- Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Does this phase 1B trial require dose / safety escalation? Or is...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 672194 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2195 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1989915 | 0.004 |
40 | 25897271 | 0.003 |
15 | 13950505 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 15547457 | 25 |
0.006 | 13217229 | 15 |
0.007 | 3200000 | 3 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 09.56am 23/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |